View source for Patientreported benefits together with firstline durvalumab as well as platinumetoposide versus platinumetoposide within extensivestage smallcell carcinoma of the lung CASPIAN a new randomized manipulated openlabel period III research
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.